• ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT

INVESTORS

[한국경제] 큐로셀 “루푸스병 신약에 도전장”…토종 맞춤형 세포치료제 임상에 뛰어들다

2025/08/12

큐로셀 루푸스병 신약에 도전장…토종 맞춤형 세포치료제 임상에 뛰어들다 | 한국경제

Prev[머니투데이] 큐로셀, 국산 최초 CAR-T 승인 초읽기…상업화 넘어 적응증 확장도 순항
Next[세계비즈] ㈜큐로셀, 대전광역시 ‘2025년 대전정착형 청년일자리 종합프로젝트’ 청끌기업 선정
Copyright 2023. Curocell Inc. All Rights Reserved.
Created by PRESSCAT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.